Pfizer COVID

• Pfizer shares sink on declining demand for COVID vaccines, treatment

  Pfizer on Wednesday forecast 2024 sales that were as much as $5 billion below Wall Street expectations due mostly to declining demand for COVID vaccines and treatment.

  Consumer

  Dec 13, 2023
  
• Health Canada OKs Pfizer’s bivalent Omicron BA.4/BA.5 booster for kids 5-11

  Health Canada has authorized Pfizer-BioNTech's bivalent COVID-19 vaccine, also known as Comirnaty, for children who are five to 11 years of age. 

  Health

  Dec 9, 2022
  
• Advertisement
• Updated Pfizer COVID-19 booster enhances protection, company says

  About 26.3 million Americans have gotten an updated booster since they rolled out in early September, according to the Centers for Disease Control and Prevention.

  World

  Nov 4, 2022
• Advertisement
• Updated Pfizer Omicron booster protects against subvariants, company says

  The companies said data from a trial in adult patients showed that the booster dose led to a substantial increase in neutralizing antibody levels against the BA.4/BA.5 variants.

  World

  Oct 13, 2022
• Health Canada OKs Pfizer COVID-19 booster shot for teens ages 16 and 17

  Health Canada cleared an extra dose of the vaccine for people 18 and older in November. The booster is meant to be administered six months after the primary two-dose series.

  Health

  Jun 1, 2022
• Paxlovid oral treatment fails to prevent COVID-19 in household members: Pfizer

  Pfizer said a large trial found that its Paxlovid treatment was not effective at preventing infection in people living with someone who had been exposed to the virus.

  Health

  Apr 29, 2022
• Pfizer’s COVID-19 pill appears effective against Omicron variant, company says

  The Canadian government announced earlier this month it has reached an agreement with Pfizer for one million courses of its treatment, pending Health Canada approval.

  Health

  Dec 14, 2021
• Pfizer to allow other companies to make its COVID-19 pill

  COVID-19 vaccine maker Pfizer has agreed to grant a license for its antiviral pill to the Medicines Patent Pool, which would allow other companies to make the treatment.

  Health

  Nov 16, 2021